Dow reports fourth quarter 2022 results
Dow (NYSE: DOW) reported its fourth quarter 2022 results, showing significant declines in both revenue and earnings. GAAP EPS was $0.85, down from $2.32 year-over-year, while operating EPS fell to $0.46 from $2.15. Net sales totaled $11.9 billion, a 17% decrease from the previous year. The company faced volume declines of 8%, particularly in Europe and North America, due to slower economic growth and customer destocking. Despite challenges, Dow generated $2.1 billion in cash flow from operations and returned $620 million to shareholders. For 2022, Dow's net sales rose to $56.9 billion, but net income dropped to $4.6 billion, down from $6.4 billion the prior year.
- Generated $2.1 billion in cash flow from operations, emphasizing strong cash management.
- Total returns to shareholders of $620 million, including $495 million in dividends and $125 million in share repurchases.
- Full year net sales increased to $56.9 billion from $55 billion in 2021.
- GAAP EPS decreased to $0.85 from $2.32 year-over-year, signaling a significant earnings decline.
- Net sales dropped 17% to $11.9 billion compared to the prior year, affecting overall revenue stability.
- Operating EBIT fell to $601 million, down $1.7 billion year-over-year, reflecting lower pricing and reduced operating rates.
FINANCIAL HIGHLIGHTS
- GAAP earnings per share (EPS) was
; operating EPS1 was$0.85 , compared to$0.46 in the year-ago period and$2.15 in the prior quarter. Operating EPS excludes significant items in the quarter, totaling$1.11 per share, primarily due to the successful and final resolution and recognition of a long-running patent infringement award.$0.39 - Net sales were
, down$11.9 billion 17% versus the year-ago period and16% sequentially, reflecting declines in all operating segments driven by slower GDP growth and customer destocking. - Local price declined
5% versus the year-ago period, driven by Packaging & Specialty Plastics. Sequentially, local price decreased6% with declines in all operating segments and regions. - Currency decreased net sales by
4% year-over-year and1% versus the prior quarter, reflecting the impact of broad-based strength of theU.S. dollar. - Volume decreased
8% versus the year-ago period, led by an18% decline inEurope , theMiddle East ,Africa , andIndia (EMEAI), and destocking in building & construction and consumer durables end-markets in theU.S. &Canada . Sequentially, volume decreased by9% with declines in all regions. - Equity losses were
,$43 million lower than the year-ago period, with declines at the Company's principal joint ventures. Equity earnings improved by$267 million from the prior quarter, due to improved earnings at the Thai and Sadara joint ventures.$15 million - GAAP net income was
. Operating EBIT1 was$647 million , down$601 million versus the year-ago period and down$1.7 billion sequentially, with declines in all operating segments due to lower pricing and reduced operating rates to match market dynamics.$594 million - Cash provided by operating activities – continuing operations was
, down$2.1 billion year-over-year and up$479 million compared to the prior quarter. Free cash flow1 was$138 million .$1.5 million - Returns to shareholders totaled
in the quarter, including$620 million in dividends and$495 million in share repurchases.$125 million - The Company delivered 2022 full year net sales of
, versus$56.9 billion in 2021. GAAP net income was$55 billion , versus$4.6 billion in 2021. Operating EBIT was$6.4 billion , versus$6.6 billion in 2021. Cash provided by operating activities – continuing operations was$9.5 billion , up from$7.5 billion in 2021. The Company delivered a cash flow conversion1 of$7.1 billion 80% and returns to shareholders totaled , through$4.3 billion in share repurchases and$2.3 billion in dividends.$2 billion
SUMMARY FINANCIAL RESULTS
Three Months Ended | Three Months Ended Sept 30 | ||||
In millions, except per share amounts | 4Q22 | 4Q21 | vs. SQLY [B / (W)] | 3Q22 | vs. PQ [B / (W)] |
GAAP Income, Net of Tax | |||||
Operating EBIT¹ | |||||
Operating EBIT Margin¹ | 5.1 % | 15.8 % | (1,070) bps | 8.5 % | (340) bps |
Operating EBITDA¹ | |||||
GAAP Earnings Per Share | |||||
Operating Earnings Per Share¹ | |||||
Cash Provided by Operating |
- Op. Earnings Per Share, Op. EBIT, Op. EBIT Margin, Op. EBITDA, and Free Cash Flow are non-GAAP measures. See page 6 for further discussion.
CEO QUOTE
"In the fourth quarter, Team Dow continued to proactively navigate slowing global growth, challenging energy markets, and destocking. In response, we shifted our focus to cash generation in the quarter as we lowered operating rates, implemented cost savings measures, and prioritized higher-value products where demand remained resilient. These actions resulted in
"Dow's distinct competitive advantages and our operational and financial discipline enabled us to deliver resilient performance in 2022, despite a challenging second half of the year. For the year, we generated
SEGMENT HIGHLIGHTS
Packaging & Specialty Plastics
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 4Q22 | 4Q21 | vs. SQLY [B / (W)] | 3Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | 10.8 % | 20.1 % | (930) bps | 10.7 % | 10 bps |
Equity Earnings |
Packaging & Specialty Plastics segment net sales in the quarter were
Equity earnings were
Operating EBIT was
Packaging and Specialty Plastics business reported a net sales decrease versus the year-ago period, as local price and volume gains in functional polymers for renewable energy applications and mobility end-markets were more than offset by lower polyethylene prices and lower industrial and consumer packaging demand in EMEAI. Sequentially, net sales decreased on lower polyethylene local prices, partly offset by improving market demand dynamics in
Hydrocarbons & Energy business reported a net sales decrease compared to the year-ago period and sequentially, driven by lower olefin and aromatic sales in the
Industrial Intermediates & Infrastructure
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 4Q22 | 4Q21 | vs. SQLY [B / (W)] | 3Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | 4.5 % | 13.1 % | (860) bps | 4.1 % | 40 bps |
Equity Earnings (Losses) |
Industrial Intermediates & Infrastructure segment net sales were
Equity losses for the segment were
Operating EBIT was
Polyurethanes & Construction Chemicals business reported a net sales decrease compared to the year-ago period, primarily driven by lower demand in EMEAI for consumer durables, industrial, and building & construction applications, as well as currency impacts. Sequentially, net sales declined due to value chain destocking and seasonality in building & construction.
Industrial Solutions business reported lower net sales compared to the year-ago period, as strong demand for pharmaceutical and energy applications was more than offset by lower volumes in coatings and industrial markets. Sequentially, net sales decreased as local price declines and lower demand in industrial end-markets were partly offset by a seasonal increase in deicing fluid demand.
Performance Materials & Coatings
Three Months Ended | Three Months Ended | ||||
In millions, except margin | 4Q22 | 4Q21 | vs. SQLY [B / (W)] | 3Q22 | vs. PQ [B / (W)] |
Operating EBIT | |||||
Operating EBIT Margin | (6.3) % | 11.5 % | (1,780) bps | 11.4 % | (1,770) bps |
Equity Earnings |
Performance Materials & Coatings segment net sales in the quarter were
Operating EBIT was a loss of
Consumer Solutions business reported a decrease in net sales versus the year-ago period, as local price gains for performance silicones applications were more than offset by lower demand and prices for siloxanes. Sequentially, net sales declined due to decreased demand in electronics and personal care end-markets, driven by year-end destocking in the value chain as well as lower demand and local prices for siloxanes.
Coatings & Performance Monomers business reported lower net sales compared to the year-ago period. Local price gains for architectural and industrial coatings were more than offset by price declines in acrylic monomers. Volume declined year-over-year on decreased demand for coatings applications in the
OUTLOOK
"As we enter 2023, we remain focused on managing near-term dynamics while continuing to position the company for long-term value creation," said Fitterling. "While we see initial positive signs from moderating inflation in the
Conference Call
Dow will host a live webcast of its fourth quarter earnings conference call with investors to discuss its results, business outlook and other matters today at
About Dow
Dow (NYSE: DOW) combines global breadth; asset integration and scale; focused innovation and materials science expertise; leading business positions; and environmental, social and governance leadership to achieve profitable growth and help deliver a sustainable future. The Company's ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company in the world. Dow's portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated, science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility and consumer applications. Dow operates manufacturing sites in 31 countries and employs approximately 37,800 people. Dow delivered sales of approximately
Cautionary Statement about Forward-Looking Statements
Certain statements in this press release are "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may," "opportunity," "outlook," "plan," "project," "seek," "should," "strategy," "target," "will," "will be," "will continue," "will likely result," "would" and similar expressions, and variations or negatives of these words or phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to risks, uncertainties and other factors that are beyond Dow's control, which may cause actual results to differ materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the date the statements were made. These factors include, but are not limited to: sales of Dow's products; Dow's expenses, future revenues and profitability; the continuing global and regional economic impacts of the coronavirus disease 2019 ("COVID-19") pandemic and other public health-related risks and events on Dow's business; any sanction, export restrictions, supply chain disruptions or increased economic uncertainty related to the ongoing conflict between
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section titled "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended
Non-GAAP Financial Measures
This earnings release includes information that does not conform to
Operating Earnings Per Share is defined as "Earnings per common share - diluted" excluding the after-tax impact of significant items.
Operating EBIT is defined as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items.
Operating EBIT Margin is defined as Operating EBIT as a percentage of net sales.
Operating EBITDA is defined as earnings (i.e., "Income before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.
Free Cash Flow is defined as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by the Company from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.
Cash Flow Conversion is defined as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.
Operating Return on
| ||||
In millions, except per share amounts (Unaudited) | Three Months Ended | Twelve Months Ended | ||
|
|
|
| |
Net sales | $ 11,859 | $ 14,364 | $ 56,902 | $ 54,968 |
Cost of sales | 10,656 | 11,778 | 48,338 | 44,191 |
Research and development expenses | 225 | 225 | 851 | 857 |
Selling, general and administrative expenses | 386 | 436 | 1,675 | 1,645 |
Amortization of intangibles | 80 | 87 | 336 | 388 |
Restructuring and asset related charges (credits) - net | (68) | (16) | 118 | 6 |
Equity in earnings (losses) of nonconsolidated affiliates | (43) | 224 | 268 | 975 |
Sundry income (expense) - net | 435 | 190 | 727 | (35) |
Interest income | 68 | 20 | 173 | 55 |
Interest expense and amortization of debt discount | 175 | 170 | 662 | 731 |
Income before income taxes | 865 | 2,118 | 6,090 | 8,145 |
Provision for income taxes | 218 | 357 | 1,450 | 1,740 |
Net income | 647 | 1,761 | 4,640 | 6,405 |
Net income attributable to noncontrolling interests | 34 | 25 | 58 | 94 |
Net income available for | $ 613 | $ 1,736 | $ 4,582 | $ 6,311 |
Per common share data: | ||||
Earnings per common share - basic | $ 0.86 | $ 2.34 | $ 6.32 | $ 8.44 |
Earnings per common share - diluted | $ 0.85 | $ 2.32 | $ 6.28 | $ 8.38 |
Weighted-average common shares outstanding - basic | 709.2 | 738.1 | 721.0 | 743.6 |
Weighted-average common shares outstanding - diluted | 713.0 | 743.3 | 725.6 | 749.0 |
| ||
In millions, except share amounts (Unaudited) |
|
|
Assets | ||
Current Assets | ||
Cash and cash equivalents | $ 3,886 | $ 2,988 |
Accounts and notes receivable: | ||
Trade (net of allowance for doubtful receivables - 2022: | 5,611 | 6,841 |
Other | 2,144 | 2,713 |
Inventories | 6,988 | 7,372 |
Other current assets | 1,848 | 934 |
Total current assets | 20,477 | 20,848 |
Investments | ||
Investment in nonconsolidated affiliates | 1,589 | 2,045 |
Other investments (investments carried at fair value - 2022: | 2,793 | 3,193 |
Noncurrent receivables | 666 | 478 |
Total investments | 5,048 | 5,716 |
Property | ||
Property | 58,055 | 57,604 |
Less: Accumulated depreciation | 37,613 | 37,049 |
Net property | 20,442 | 20,555 |
Other Assets | ||
8,644 | 8,764 | |
Other intangible assets (net of accumulated amortization - 2022: | 2,442 | 2,881 |
Operating lease right-of-use assets | 1,227 | 1,412 |
Deferred income tax assets | 960 | 1,358 |
Deferred charges and other assets | 1,363 | 1,456 |
Total other assets | 14,636 | 15,871 |
Total Assets | $ 60,603 | $ 62,990 |
Liabilities and Equity | ||
Current Liabilities | ||
Notes payable | $ 362 | $ 161 |
Long-term debt due within one year | 362 | 231 |
Accounts payable: | ||
Trade | 4,940 | 5,577 |
Other | 2,276 | 2,839 |
Operating lease liabilities - current | 287 | 314 |
Income taxes payable | 334 | 623 |
Accrued and other current liabilities | 2,770 | 3,481 |
Total current liabilities | 11,331 | 13,226 |
Long-Term Debt | 14,698 | 14,280 |
Other Noncurrent Liabilities | ||
Deferred income tax liabilities | 1,110 | 506 |
Pension and other postretirement benefits - noncurrent | 3,808 | 7,557 |
Asbestos-related liabilities - noncurrent | 857 | 931 |
Operating lease liabilities - noncurrent | 997 | 1,149 |
Other noncurrent obligations | 6,555 | 6,602 |
Total other noncurrent liabilities | 13,327 | 16,745 |
Stockholders' Equity | ||
Common stock (authorized 5,000,000,000 shares of issued 2022: 771,678,525 shares; 2021: 764,226,882 shares) | 8 | 8 |
Additional paid-in capital | 8,540 | 8,151 |
Retained earnings | 23,180 | 20,623 |
Accumulated other comprehensive loss | (7,139) | (8,977) |
Unearned ESOP shares | — | (15) |
(3,871) | (1,625) | |
20,718 | 18,165 | |
Noncontrolling interests | 529 | 574 |
Total equity | 21,247 | 18,739 |
Total Liabilities and Equity | $ 60,603 | $ 62,990 |
| ||
In millions (Unaudited) For the years ended | 2022 | 2021 |
Operating Activities | ||
Net income | $ 4,640 | $ 6,405 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 2,758 | 2,842 |
Provision for deferred income tax | 79 | 278 |
Earnings of nonconsolidated affiliates less than (in excess of) dividends received | 696 | (651) |
Net periodic pension benefit cost | 23 | 39 |
Pension contributions | (235) | (1,219) |
Net gain on sales of assets, businesses and investments | (19) | (105) |
Restructuring and asset related charges - net | 118 | 6 |
Other net loss | 212 | 921 |
Changes in assets and liabilities, net of effects of acquired and divested companies: | ||
Accounts and notes receivable | 1,187 | (2,132) |
Inventories | 347 | (1,768) |
Accounts payable | (1,255) | 2,458 |
Other assets and liabilities, net | (1,065) | (5) |
Cash provided by operating activities - continuing operations | 7,486 | 7,069 |
Cash used for operating activities - discontinued operations | (11) | (60) |
Cash provided by operating activities | 7,475 | 7,009 |
Investing Activities | ||
Capital expenditures | (1,823) | (1,501) |
Investment in gas field developments | (190) | (92) |
Purchases of previously leased assets | (7) | (694) |
Proceeds from sales of property and businesses, net of cash divested | 32 | 68 |
Acquisitions of property and businesses, net of cash acquired | (228) | (129) |
Investments in and loans to nonconsolidated affiliates | (148) | — |
Distributions and loan repayments from nonconsolidated affiliates | 52 | 51 |
Proceeds from sales of ownership interests in nonconsolidated affiliates | 11 | — |
Purchases of investments | (1,366) | (1,366) |
Proceeds from sales and maturities of investments | 747 | 759 |
Other investing activities, net | (50) | (10) |
Cash used for investing activities | (2,970) | (2,914) |
Financing Activities | ||
Changes in short-term notes payable | 253 | (48) |
Proceeds from issuance of short-term debt greater than three months | — | 144 |
Payments on short-term debt greater than three months | (14) | (130) |
Proceeds from issuance of long-term debt | 1,667 | 109 |
Payments on long-term debt | (1,006) | (2,771) |
Purchases of treasury stock | (2,325) | (1,000) |
Proceeds from issuance of stock | 212 | 320 |
Transaction financing, debt issuance and other costs | (24) | (537) |
Employee taxes paid for share-based payment arrangements | (35) | (12) |
Distributions to noncontrolling interests | (83) | (73) |
Dividends paid to stockholders | (2,006) | (2,073) |
Cash used for financing activities | (3,361) | (6,071) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (237) | (99) |
Summary | ||
Increase (decrease) in cash, cash equivalents and restricted cash | 907 | (2,075) |
Cash, cash equivalents and restricted cash at beginning of year | 3,033 | 5,108 |
Cash, cash equivalents and restricted cash at end of year | $ 3,940 | $ 3,033 |
Less: Restricted cash and cash equivalents, included in "Other current assets" | 54 | 45 |
Cash and cash equivalents at end of year | $ 3,886 | $ 2,988 |
Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
|
Packaging & Specialty Plastics | $ 6,073 | $ 7,189 | $ 29,260 | $ 28,128 |
Industrial Intermediates & Infrastructure | 3,653 | 4,548 | 16,606 | 16,851 |
Performance Materials & Coatings | 2,058 | 2,558 | 10,764 | 9,672 |
Corporate | 75 | 69 | 272 | 317 |
Total | $ 11,859 | $ 14,364 | $ 56,902 | $ 54,968 |
$ 4,367 | $ 5,182 | $ 20,945 | $ 19,613 | |
EMEAI 1 | 3,808 | 5,086 | 19,631 | 19,746 |
2,347 | 2,620 | 10,344 | 10,043 | |
1,337 | 1,476 | 5,982 | 5,566 | |
Total | $ 11,859 | $ 14,364 | $ 56,902 | $ 54,968 |
Net Sales Variance by Segment and | Three Months Ended | Twelve Months Ended | |||||||
Local | Currency | Volume | Total | Local | Currency | Volume | Total | ||
Percent change from prior year | |||||||||
Packaging & Specialty Plastics | (9) % | (3) % | (4) % | (16) % | 7 % | (3) % | — % | 4 % | |
Industrial Intermediates & Infrastructure | (1) | (5) | (14) | (20) | 11 | (5) | (7) | (1) | |
Performance Materials & Coatings | (2) | (5) | (13) | (20) | 21 | (4) | (6) | 11 | |
Total | (5) % | (4) % | (8) % | (17) % | 11 % | (4) % | (3) % | 4 % | |
Total, excluding the Hydrocarbons & | (4) % | (4) % | (9) % | (17) % | 10 % | (4) % | (5) % | 1 % | |
(7) % | — % | (9) % | (16) % | 6 % | — % | 1 % | 7 % | ||
EMEAI 1 | 1 | (8) | (18) | (25) | 18 | (9) | (10) | (1) | |
(10) | (5) | 5 | (10) | 6 | (3) | — | 3 | ||
(8) | — | (1) | (9) | 6 | — | 1 | 7 | ||
Total | (5) % | (4) % | (8) % | (17) % | 11 % | (4) % | (3) % | 4 % |
Net Sales Variance by Segment and | Three Months Ended | ||||
Local | Currency | Volume | Total | ||
Percent change from prior quarter | |||||
Packaging & Specialty Plastics | (9) % | (1) % | (7) % | (17) % | |
Industrial Intermediates & Infrastructure | (2) | (1) | (7) | (10) | |
Performance Materials & Coatings | (6) | (1) | (15) | (22) | |
Total | (6) % | (1) % | (9) % | (16) % | |
Total, excluding the Hydrocarbons & Energy business | (6) % | (1) % | (6) % | (13) % | |
(7) % | — % | (11) % | (18) % | ||
EMEAI 1 | (5) | (1) | (12) | (18) | |
(6) | (2) | (1) | (9) | ||
(9) | — | (6) | (15) | ||
Total | (6) % | (1) % | (9) % | (16) % |
Europe ,Middle East ,Africa , andIndia .
| |||||
Operating EBIT by Segment | Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
| |
Packaging & Specialty Plastics | $ 655 | $ 1,442 | $ 4,110 | $ 6,638 | |
Industrial Intermediates & Infrastructure | 164 | 595 | 1,418 | 2,282 | |
Performance Materials & Coatings | (130) | 295 | 1,328 | 866 | |
Corporate | (88) | (67) | (266) | (253) | |
Total | $ 601 | $ 2,265 | $ 6,590 | $ 9,533 | |
Depreciation and Amortization by Segment | Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
| |
Packaging & Specialty Plastics | $ 320 | $ 316 | $ 1,396 | $ 1,358 | |
Industrial Intermediates & Infrastructure | 132 | 131 | 550 | 612 | |
Performance Materials & Coatings | 197 | 200 | 789 | 842 | |
Corporate | 5 | 8 | 23 | 30 | |
Total | $ 654 | $ 655 | $ 2,758 | $ 2,842 | |
Operating EBITDA by Segment | Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
| |
Packaging & Specialty Plastics | $ 975 | $ 1,758 | $ 5,506 | $ 7,996 | |
Industrial Intermediates & Infrastructure | 296 | 726 | 1,968 | 2,894 | |
Performance Materials & Coatings | 67 | 495 | 2,117 | 1,708 | |
Corporate | (83) | (59) | (243) | (223) | |
Total | $ 1,255 | $ 2,920 | $ 9,348 | $ 12,375 | |
Equity in Earnings (Losses) of Nonconsolidated | Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
| |
Packaging & Specialty Plastics | $ 56 | $ 130 | $ 359 | $ 490 | |
Industrial Intermediates & Infrastructure | (96) | 90 | (91) | 471 | |
Performance Materials & Coatings | 4 | 2 | 10 | 7 | |
Corporate | (7) | 2 | (10) | 7 | |
Total | $ (43) | $ 224 | $ 268 | $ 975 | |
Reconciliation of "Net Income" to "Operating EBIT" | Three Months Ended | Twelve Months Ended | |||
In millions (Unaudited) |
|
|
|
|
|
Net income | $ 760 | $ 647 | $ 1,761 | $ 4,640 | $ 6,405 |
+ Provision for income taxes | 241 | 218 | 357 | 1,450 | 1,740 |
Income before income taxes | $ 1,001 | $ 865 | $ 2,118 | $ 6,090 | $ 8,145 |
- Interest income | 41 | 68 | 20 | 173 | 55 |
+ Interest expense and amortization of debt discount | 155 | 175 | 170 | 662 | 731 |
- Significant items | (80) | 371 | 3 | (11) | (712) |
Operating EBIT (non-GAAP) | $ 1,195 | $ 601 | $ 2,265 | $ 6,590 | $ 9,533 |
| ||||
Significant Items Impacting Results for the Three Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 865 | $ 613 | $ 0.85 | |
Less: Significant items | ||||
Digitalization program costs 4 | (76) | (64) | (0.09) | Cost of sales ( |
Restructuring, implementation costs and | (9) | (7) | (0.01) | Cost of sales ( |
68 | 56 | 0.08 | Restructuring and asset related charges - net | |
Litigation related charges, awards and | 381 | 288 | 0.40 | Sundry income (expense) - net |
Indemnifications and other transaction related | 7 | 7 | 0.01 | Sundry income (expense) - net |
Total significant items | $ 371 | $ 280 | $ 0.39 | |
Operating results (non-GAAP) | $ 494 | $ 333 | $ 0.46 |
Significant Items Impacting Results for the Three Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 2,118 | $ 1,736 | $ 2.32 | |
Less: Significant items | ||||
Digitalization program costs 4 | (48) | (38) | (0.05) | Cost of sales ( |
Restructuring, implementation costs and | — | — | — | Cost of sales ( |
Net gain on divestiture and asset sale | 16 | 16 | 0.02 | Sundry income (expense) - net |
Indemnification and other transaction related | 35 | 35 | 0.05 | Sundry income (expense) - net |
Income tax related items 9 | — | 111 | 0.15 | Provision for income taxes on continuing |
Total significant items | $ 3 | $ 124 | $ 0.17 | |
Operating results (non-GAAP) | $ 2,115 | $ 1,612 | $ 2.15 |
- "Income before income taxes."
- "Net income available for
Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. - "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
- Costs associated with implementing the Company's Digital Acceleration program.
- Includes restructuring charges, asset related charges, and costs associated with implementing the Company's 2020 Restructuring Program.
- Partial reversal of certain asset related reserves recorded in the first quarter of 2022 related to the conflict between
Russia andUkraine . - Related to a gain associated with a legal matter with
Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability. - Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
- Related to reversals of certain tax valuation allowances partially offset by charges related to uncertain tax positions.
| ||||
Significant Items Impacting Results for the Twelve Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 6,090 | $ 4,582 | $ 6.28 | |
Less: Significant items | ||||
Digitalization program costs 4 | (230) | (183) | (0.25) | Cost of sales ( |
Restructuring, implementation costs and | (40) | (32) | (0.04) | Cost of sales ( |
(118) | (86) | (0.11) | Restructuring and asset related charges - net | |
Loss on early extinguishment of debt | (8) | (6) | (0.01) | Sundry income (expense) - net |
Litigation related charges, awards and | 381 | 288 | 0.40 | Sundry income (expense) - net |
Indemnifications and other transaction related | 4 | 4 | 0.01 | Sundry income (expense) - net |
Income tax related items | — | 25 | 0.03 | Provision for income taxes on continuing |
Total significant items | $ (11) | $ 10 | $ 0.03 | |
Operating results (non-GAAP) | $ 6,101 | $ 4,572 | $ 6.25 |
Significant Items Impacting Results for the Twelve Months Ended | ||||
In millions, except per share amounts (Unaudited) | Pretax 1 | Net | EPS 3 | Income Statement Classification |
Reported results | $ 8,145 | $ 6,311 | $ 8.38 | |
Less: Significant items | ||||
Digitalization program costs 4 | (169) | (132) | (0.17) | Cost of sales ( |
Restructuring, implementation costs and | (69) | (55) | (0.07) | Cost of sales ( |
Loss on early extinguishment of debt | (574) | (471) | (0.63) | Sundry income (expense) - net |
Net gain on divestitures and asset sale | 16 | 16 | 0.02 | Sundry income (expense) - net |
Litigation related charges, awards and | 54 | 42 | 0.06 | Sundry income (expense) - net |
Indemnification and other transaction related | 30 | 30 | 0.04 | Sundry income (expense) - net |
Income tax related items 9 | — | 111 | 0.15 | Provision for income taxes on continuing |
Total significant items | $ (712) | $ (459) | $ (0.60) | |
Operating results (non-GAAP) | $ 8,857 | $ 6,770 | $ 8.98 |
- "Income before income taxes."
- "Net income available for
Dow Inc. common stockholders." The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. - "Earnings per common share - diluted," which includes the impact of participating securities in accordance with the two-class method.
- Costs associated with implementing the Company's Digital Acceleration program.
- Includes restructuring charges, asset related charges, and costs associated with implementing the Company's 2020 Restructuring Program.
- Asset related charges including inventory write-downs, bad debt reserves, and impairments of other assets related to the conflict between
Russia andUkraine . - Related to a gain associated with a legal matter with
Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability. - Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
- Related to reversals of certain tax valuation allowances partially offset by charges related to uncertain tax positions.
| ||||
Reconciliation of Free Cash Flow | Three Months Ended | Twelve Months Ended | ||
In millions (Unaudited) |
|
|
|
|
Cash provided by operating activities - continuing operations (GAAP) | $ 2,078 | $ 2,557 | $ 7,486 | $ 7,069 |
Capital expenditures | (599) | (466) | (1,823) | (1,501) |
Free Cash Flow (non-GAAP) 1 | $ 1,479 | $ 2,091 | $ 5,663 | $ 5,568 |
- Free Cash Flow for the twelve months ended
December 31, 2021 reflects a elective pension contribution.$1 billion
Reconciliation of Cash Flow Conversion | Three Months Ended | ||||
|
|
|
| ||
In millions (Unaudited) | |||||
Cash provided by operating activities - continuing operations (GAAP) | $ 1,612 | $ 1,856 | $ 1,940 | $ 2,078 | |
Operating EBITDA (non-GAAP) | $ 3,171 | $ 3,059 | $ 1,863 | $ 1,255 | |
Cash Flow Conversion (Operating EBITDA to cash flow from operations) | 50.8 % | 60.7 % | 104.1 % | 165.6 % | |
Cash Flow Conversion - trailing twelve months (non-GAAP) | 80.1 % |
For further information, please contact: | |
Investors: +1 989-638-5265 | Media: +1 989-638-2417 |
Facebook: https://www.facebook.com/dow/
LinkedIn: http://www.linkedin.com/company/dow-chemical
Instagram: http://instagram.com/dow_official
View original content to download multimedia:https://www.prnewswire.com/news-releases/dow-reports-fourth-quarter-2022-results-301731402.html
SOURCE
FAQ
What were Dow's earnings per share for Q4 2022?
How much did net sales decline for Dow in Q4 2022?
What were the main factors impacting Dow's Q4 2022 performance?
How much cash flow did Dow generate from operations in the fourth quarter?